Carvedilol Tablet, Film Coated
Product Images NDC 67296-2298

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 67296-2298). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph comparing mortality percentage over 21 months between two groups labeled Placebo and Carvedilol. The y-axis represents % Mortality and the x-axis represents Months. The Carvedilol line shows consistently lower mortality than placebo, with a p-value of 0.0014 indicating statistical significance.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot chart displaying hazard ratios with confidence intervals for various patient subgroups including men, women, different age groups, racial groups, diabetic status, ischemic conditions, heart rate levels, systolic blood pressure levels, and spironolactone usage, as well as all patients combined. The horizontal axis is labeled 'Hazard ratio' and ranges from 0.0 to 2.0, with a vertical dashed line at 1.0 for reference.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A survival analysis graph titled 'Figure 3. Survival Analysis for CAPRICORN (intent-to-treat)' showing percentage mortality over 24 months. The x-axis represents time in months, and the y-axis represents percentage mortality from 0 to 30%. Two curves compare mortality for Placebo and Carvedilol groups, with Carvedilol showing lower mortality over time. A p-value of 0.03 is indicated.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A figure titled 'Effects on Mortality for Subgroups in CAPRICORN' showing hazard ratios for various subgroups. The chart compares mortality hazard ratios within subgroups defined by age, sex, timing post-myocardial infarction, prior beta blocker use, Killip class, thrombolytic therapy, PTCA for MI, heart failure status, diuretics use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Data points are plotted with confidence intervals along a horizontal hazard ratio axis ranging approximately from 0.4 to 1.3.*
FDA Label Image

Label125mg100s (Label125mg100s)

Label125mg100s (Label125mg100s)
Label for Carvedilol Tablets, USP 12.5 mg, film-coated tablets. The label indicates a package containing 100 tablets, distributed by Glenmark Pharmaceuticals Inc., USA. The label includes storage instructions and barcode, with a reference to Rx only usage.*
FDA Label Image

Label25mg100s (Label25mg100s)

Label25mg100s (Label25mg100s)
Carvedilol Tablets, USP 25 mg film-coated tablet bottle label. The label features the Glenmark logo and indicates a prescription-only drug with a package size of 100 tablets. Storage and usage information is included, along with distributor information for Glenmark Pharmaceuticals Inc., USA. The label also displays an NDC barcode.*
FDA Label Image

Label3125mg100s (Label3125mg100s)

Label3125mg100s (Label3125mg100s)
This label is for Carvedilol Tablets USP 3.125 mg by Glenmark Pharmaceuticals. It shows a 100-tablet prescription package. The label includes storage instructions, distributor contact information, and safety warnings. The NDC on the label is 68462-162-01.*
FDA Label Image

Label625mg100s (Label625mg100s)

Label625mg100s (Label625mg100s)
Carvedilol Tablets USP 6.25 mg film-coated tablets packaging label showing NDC 68462-163-01, manufactured by Glenmark Pharmaceuticals Inc., USA. The label indicates 100 tablets per container, for oral use, with storage instructions to keep at 20°C to 25°C and protect from moisture. The label includes dispensing and safety information with a barcode on the right side.*
FDA Label Image
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Carvedilol-chemical-structure (Structure)

Carvedilol-chemical-structure (Structure)
Chemical structure of carvedilol active ingredient showing the molecular arrangement including aromatic rings, hydroxyl group, and ether linkages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.